Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli

被引:591
作者
Buechler, C [1 ]
Ritter, M [1 ]
Orsó, E [1 ]
Langmann, T [1 ]
Klucken, J [1 ]
Schmitz, G [1 ]
机构
[1] Klinikum Univ Regensburg, Inst Klin Chem & Lab Med, D-93042 Regensburg, Germany
关键词
interleukin-10; interferon-gamma; inflammation; tumor necrosis factor alpha;
D O I
10.1002/jlb.67.1.97
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD163, also referred to as M130, member of the scavenger receptor cysteine-rich family (SRCR) is exclusively expressed on cells of the monocyte lineage. In freshly isolated monocytes the CD14(bright) CD16(+) monocyte subset revealed the highest expression of CD163 among all monocyte subsets. CD163 mRNA and protein expression is up-regulated during macrophage colony-stimulating factor (M-CSF)-dependent phagocytic differentiation of human blood monocytes, In contrast, monocytic cells treated with GM-CSF and interleukin-4 (IL-P) for dendritic differentiation down-regulate this antigen. CD163 expression is also suppressed by proinflammatory mediators like lipopolysaccharide (LPS), interferon-gamma (IFN-gamma), and tumor necrosis factor alpha, whereas IL-6 and the antiinflammatory cytokine interleukin-10 (IL-10) strongly up-regulate CD163 mRNA in monocytes and macrophage. The effects of the immunosuppressants dexamethasone, cyclosporin A (CA), and cortisol differ in their capacity to influence CD163 mRNA levels, Our results demonstrate that CD163 expression in monocytes/macrophages is regulated by proinflammatory and antiinflammatory mediators, This expression pattern implies a functional role of CD163 in the antiinflammatory response of monocytes.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 48 条
[1]  
Akira S, 1996, Curr Opin Hematol, V3, P87
[2]   CD6-ligand interactions: a paradigm for SRCR domain function? [J].
Aruffo, A ;
Bowen, MA ;
Patel, DD ;
Haynes, BF ;
Starling, GC ;
Gebe, JA ;
Bajorath, J .
IMMUNOLOGY TODAY, 1997, 18 (10) :498-504
[3]  
Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936
[4]   BER-MAC3 - NEW MONOCLONAL-ANTIBODY THAT DEFINES HUMAN MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN [J].
BACKE, E ;
SCHWARTING, R ;
GERDES, J ;
ERNST, M ;
STEIN, H .
JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (11) :936-945
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]   CONTINUOUS GROWTH AND DIFFERENTIATION OF HUMAN MYELOID LEUKEMIC-CELLS IN SUSPENSION CULTURE [J].
COLLINS, SJ ;
GALLO, RC ;
GALLAGHER, RE .
NATURE, 1977, 270 (5635) :347-349
[7]  
EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO
[8]  
2-4
[9]   Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence [J].
Greaves, DR ;
Gough, PJ ;
Gordon, S .
CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (05) :425-432
[10]   LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN ACCELERATES THE BINDING OF LPS TO CD14 [J].
HAILMAN, E ;
LICHENSTEIN, HS ;
WURFEL, MM ;
MILLER, DS ;
JOHNSON, DA ;
KELLEY, M ;
BUSSE, LA ;
ZUKOWSKI, MM ;
WRIGHT, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :269-277